212 related articles for article (PubMed ID: 34332307)
1. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Joshi P; Shrivastava R; Bhagwat S; Patel M
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
[TBL] [Abstract][Full Text] [Related]
2. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
[TBL] [Abstract][Full Text] [Related]
3. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
Landman D; Bratu S; Quale J
J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371
[TBL] [Abstract][Full Text] [Related]
4. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
[TBL] [Abstract][Full Text] [Related]
5. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
6. Effect of Porins and bla
Balabanian G; Rose M; Manning N; Landman D; Quale J
Microb Drug Resist; 2018 Sep; 24(7):877-881. PubMed ID: 29782237
[TBL] [Abstract][Full Text] [Related]
7.
Moya B; Barcelo IM; Cabot G; Torrens G; Palwe S; Joshi P; Umarkar K; Takalkar S; Periasamy H; Bhagwat S; Patel M; Bou G; Oliver A
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782985
[TBL] [Abstract][Full Text] [Related]
8. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020.
Lee YL; Ko WC; Lee WS; Lu PL; Chen YH; Cheng SH; Lu MC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Shao PL; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2021 Sep; 58(3):106377. PubMed ID: 34166777
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19).
Sader HS; Mendes RE; Duncan LR; Carvalhaes CG; Castanheria M
J Antimicrob Chemother; 2022 Sep; 77(10):2642-2649. PubMed ID: 35897129
[TBL] [Abstract][Full Text] [Related]
12. Molecular Characterization of WCK 5222 (Cefepime/Zidebactam)-Resistant Mutants Developed from a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate.
Pan X; Zhao X; Song Y; Ren H; Tian Z; Liang Q; Jin Y; Bai F; Cheng Z; Feng J; Wu W
Microbiol Spectr; 2022 Feb; 10(1):e0267821. PubMed ID: 35196805
[TBL] [Abstract][Full Text] [Related]
13. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
[TBL] [Abstract][Full Text] [Related]
14. WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015.
Sader HS; Castanheira M; Huband M; Jones RN; Flamm RK
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242660
[TBL] [Abstract][Full Text] [Related]
15. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
[TBL] [Abstract][Full Text] [Related]
16. β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae.
Khalifa SM; Abd El-Aziz AM; Hassan R; Abdelmegeed ES
PLoS One; 2021; 16(5):e0251594. PubMed ID: 34014957
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Genetic Background of KPC-2-Producing
Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
[TBL] [Abstract][Full Text] [Related]
18. Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.
Sugawara E; Kojima S; Nikaido H
J Bacteriol; 2016 Dec; 198(23):3200-3208. PubMed ID: 27645385
[TBL] [Abstract][Full Text] [Related]
19. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
[TBL] [Abstract][Full Text] [Related]
20.
Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
